Anlon Healthcare credit ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026
43.7
39.3
0.17×
0.15×
0.92×
0.83×
12.30×
14.6%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AHCL₹25.11

Anlon Healthcare Limited

· Pharma & Health
₹ CrorePeersANUHPHRWANBURYBAJAJHCAREZIMLABTHEMISMEDLINCOLNSIGACHIVALIANTLABMcap ₹133 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Total Debt43.7
Net Debt39.3
Total Debt/Equity0.17
Net Debt/Equity0.15
Total Debt/EBITDA0.92
Net Debt/EBITDA0.83
Interest Coverage (EBIT/Interest)12.30
Total Debt/Total Capital %14.63
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.